Cardio-oncology
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with tumor and receiving radiotherapy, chemotherapy, biologics, surgery/interventional surgery; 2. Age 18-85; 3. The expected survival of the patients was greater than 12 months; 4. Patients with good compliance who volunteered for follow-up
Exclusion criteria
Exclusion criteria: 1. Unable to tolerate imaging evaluation of cardiac structure and function due to severe disease; 2. Have a history of drug abuse; 3. Blood biomarkers and imaging indicators cannot be reviewed regularly at follow-up visits; 4. End-stage renal failure (defined as glomerular filtration rate less than 15ml/min.m2); 5. Inability to tolerate cardiopulmonary tests
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause death;Cardiovascular death;All-cause rehospitalization;Cardiovascular rehospitalization; | — |
Secondary
| Measure | Time frame |
|---|---|
| High sensitivity troponin I;B-type natriuretic peptide;Left ventricular ejection fraction;Left ventricular end-diastolic internal diameter; | — |
Countries
China
Contacts
The First Affiliated Hospital of Dalian Medical University